Why is Prim SA ?
1
High Debt company with Weak Long Term Fundamental Strength
2
With ROE of 11.56%, it has a Very Expensive valuation with a 1.74 Price to Book Value
- Over the past year, while the stock has generated a return of 34.06%, its profits have risen by 42% ; the PEG ratio of the company is 0.4
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Prim SA for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Prim SA
34.06%
0.02
24.78%
Spain IBEX 35
36.61%
2.23
17.30%
Quality key factors
Factor
Value
Sales Growth (5y)
16.99%
EBIT Growth (5y)
14.03%
EBIT to Interest (avg)
15.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.38
Tax Ratio
24.30%
Dividend Payout Ratio
56.66%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
256.99%
ROE (avg)
232.45%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.74
EV to EBIT
12.75
EV to EBITDA
8.74
EV to Capital Employed
1.74
EV to Sales
1.17
PEG Ratio
0.36
Dividend Yield
9.03%
ROCE (Latest)
13.64%
ROE (Latest)
11.56%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend






